Clinical Trials Arena August 29, 2024
The VPAG programme will establish 18 new trial hubs to expedite the development of new medicines for patients.
The UK Government has announced the launch of the Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) investment programme, with up to £400m investment to strengthen clinical trials.
The joint public-private investment programme will channel investments into the nation’s health and life sciences sector for the next five years.
This initiative is set to offer National Health Service (NHS) patients earlier access to new treatments and enhance the UK’s health research capabilities.
It will establish 18 new clinical trial hubs to expedite the development of new medicines for patients.
By optimising processes, the programme will ensure that new therapies rapidly...
Today's Sponsors
Today's Sponsor